Bluebee

About:

Bluebee offers a secure global bio-informatics platform to process, analyze, share and store genomics data.

Website: https://www.bluebee.com/

Twitter/X: bluebeegenomics

Top Investors: Capricorn Partners, Korys, Buysse & Partners

Description:

Bluebee is a leading provider of high performance genomics solutions, enabling research and clinical labs to substantially reduce cost and time-to-diagnose. Bluebee provides a unique cloud-based accelerated genomics platform to enable fast, efficient and affordable processing of large volumes of genomics data. Genetic analyses are currently undergoing extreme changes as a result of revolutionary developments in next generation DNA sequencing technology. While personalized treatment comes with great promises, routine clinical implementation of whole genome based diagnostics is still faced with major technological and biological challenges: the ever-growing amounts of data generated, the inherent need for faster data processing and deep analytics, and the increasing necessity of flexibility and reliability resulting from the vastness of the application spectrum.

Total Funding Amount:

11.8M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Rijswijk, Zuid-Holland, The Netherlands

Founded Date:

2011-01-01

Contact Email:

info(AT)bluebee.com

Founders:

Koen Bertels

Number of Employees:

11-50

Last Funding Date:

2016-03-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai